| Almonte, M., Ferreccio, C., Winkler, J. L., Cuzick, J., Tsu, V., Robles, S., Takahashi, R., & Sasieni, P. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru, Int.J.Cancer, vol. 121, no. 4, pp. 796-802. |
| Arrossi, S., Matos, E., Zengarini, N., Roth, B., Sankaranayananan, R., & Parkin, M. The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study, Gynecol.Oncol., vol. 105, no. 2, pp. 335-340. |
| Attard, G., Clark, J., Ambroisine, L., Fisher, G., Kovacs, G., Flohr, P., Berney, D., Foster, C. S., Fletcher, A., Gerald, W. L., Moller, H., Reuter, V., De Bono, J. S., Scardino, P., Cuzick, J., & Cooper, C. S. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer, Oncogene, vol. 27, no. 3, pp. 253-263. |
| Berney, D. M., Fisher, G., Kattan, M. W., Oliver, R. T., Moller, H., Fearn, P., Eastham, J., Scardino, P., Cuzick, J., Reuter, V. E., & Foster, C. S. Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome, Histopathology, vol. 51, no. 4, pp. 452-457. |
| Berney, D. M., Fisher, G., Kattan, M. W., Oliver, R. T., Moller, H., Fearn, P., Eastham, J., Scardino, P., Cuzick, J., Reuter, V. E., & Foster, C. S. Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading, BJU.Int., vol. 100, no. 6, pp. 1240-1244. |
| Berrington de Gonzalez A, Green, J., & Collaborators (inc.Cuzick, J. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies, Int.J.Cancer, vol. 120, no. 4, pp. 885-891. |
| Brenner, H., Coebergh, J. W., Parkin, D. M., Izarzugaza, I., Clavel, J., Arndt, V., & Steliarova-Foucher, E. Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas, Ann.Oncol., vol. 18, no. 9, pp. 1569-1577. |
| Cafferty, F. H., Wong, J. M., Yen, A. M., Duffy, S. W., Atkin, W. S., & Chen, T. H. Findings at follow-up endoscopies in subjects with suspected colorectal abnormalities: effects of baseline findings and time to follow-up, Cancer J., vol. 13, no. 4, pp. 263-270. |
| Cassidy, A., Duffy, S. W., Myles, J. P., Liloglou, T., & Field, J. K. Lung cancer risk prediction: a tool for early detection, Int.J.Cancer, vol. 120, no. 1, pp. 1-6. |
| Chiu, Y. H., Lin, W. Y., Wang, P. E., Chen, Y. D., Wang, T. T., Warwick, J., & Chen, T. H. Population-based family case-control proband study on familial aggregation of metabolic syndrome: finding from Taiwanese people involved in Keelung community-based integrated screening (KCIS no. 5), Diabetes Res.Clin.Pract., vol. 75, no. 3, pp. 348-356. |
| Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial, J.Natl.Cancer Inst., vol. 99, no. 4, pp. 272-282. |
| Cuzick, J., Cafferty, F. H., Edwards, R., Moller, H., & Duffy, S. W. Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial, J.Med.Screen., vol. 14, no. 4, pp. 178-185. |
| Cuzick, J. The ATAC trial: the vanguard trial for use of aromatase inhibitors in early breast cancer, Expert.Rev.Anticancer Ther., vol. 7, no. 8, pp. 1089-1094. |
| Cuzick, J., Ambroisine, L., Davidson, N., Jakesz, R., Kaufmann, M., Regan, M., & Sainsbury, R. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials, Lancet, vol. 369, no. 9574, pp. 1711-1723. |
| Cuzick, J., Sasieni, P., Myles, J., & Tyrer, J. Estimating the effect of treatment in a proportional hazards model in the presence of non-compliance and contamination, J R Stat Soc [B], vol. 69, no. 4, pp. 565-566. |
| Duffy, S. W., Jonsson, H., Agbaje, O. F., Pashayan, N., & Gabe, R. Avoiding bias from aggregate measures of exposure, J Epidemiol.Community Health, vol. 61, no. 5, pp. 461-463. |
| Duffy, S. W. Case-control studies to evaluate the effect of mammographic service screening on mortality from breast cancer, Semin Breast Dis, vol. 10, no. 2, pp. 61-63. |
| Duffy, S. W., Tabar, L., Chen, T., Yen, A., Gabe, R., & Smith, R. Methodologic issues in the evaluation of service screening, Semin Breast Dis, vol. 10, no. 2, pp. 68-71. |
| Gabe, R., Tryggvadottir, L., Sigfusson, B. F., Olafsdottir, G. H., Sigurdsson, K., & Duffy, S. W. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death, Acta Radiol., vol. 48, no. 9, pp. 948-955. |
| Giorgi-Rossi, P., Segnan, N., Zappa, M., Naldoni, C., Zorzi, M., Confortini, M., Merito, M., Cuzick, J., & Ronco, G. The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective, Int.J Cancer, vol. 121, no. 12, pp. 2729-2734. |
| Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thurlimann, B., Senn, H. J., & Panel Members (inc.Cuzick J). 10th St. Gallen conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007, Ann.Oncol., vol. 18, no. 7, pp. 1133-1144. |
| Gorlov, I. P., Meyer, P., Liloglou, T., Myles, J., Boettger, M. B., Cassidy, A., Girard, L., Minna, J. D., Fischer, R., Duffy, S., Spitz, M. R., Haeussinger, K., Kammerer, S., Cantor, C., Dierkesmann, R., Field, J. K., & Amos, C. I. Seizure 6-like (SEZ6L) gene and risk for lung cancer, Cancer Res., vol. 67, no. 17, pp. 8406-8411. |
| Hughes, S., Agbaje, O., Bowen, R. L., Holliday, D. L., Shaw, J. A., Duffy, S., & Jones, J. L. Matrix Metalloproteinase Single-Nucleotide Polymorphisms and Haplotypes Predict Breast Cancer Progression, Clinical Cancer Research, vol. 13, no. 22, pp. 6673-6680. |
| International Collaboration of Epidemiological Studies of Cervical Cancer (inc.Cuzick J). Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies, Lancet, vol. 370, no. 9599, pp. 1609-1621. |
| Khanna, N., Mishra, S. I., Tian, G., Tan, M. T., Arnold, S., Lee, C., Ramachandran, S., Bell, L., Baquet, C. R., & Lorincz, A. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens, Int.J Gynecol.Cancer, vol. 17, no. 3, pp. 615-622. |
| Kitchener, H., Nelson, L., Adams, J., Mesher, D., Sasieni, P., Cubie, H., Moore, C., Heard, I., Agarossi, A., Casolati, E., Denny, L., Bradbeer, C., Lyons, F., Beattie, G., & Niemiec, T. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women, Int.J.Cancer, vol. 121, no. 11, pp. 2484-2491. |
| Prospective Studies Collaboration (inc.Duffy S). Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths, Lancet, vol. 370, no. 9602, pp. 1829-1839. |
| Purushotham, A. D., Bennett Britton, T. M., Klevesath, M. B., Chou, P., Agbaje, O. F., & Duffy, S. W. Lymph node status and breast cancer-related lymphedema, Ann.Surg., vol. 246, no. 1, pp. 42-45. |
| Roemeling, S., Roobol, M. J., Otto, S. J., Habbema, D. F., Gosselaar, C., Lous, J. J., Cuzick, J., & Schroder, F. H. Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial, Prostate, vol. 67, no. 10, pp. 1053-1060. |
| Ronco, G., Brezzi, S., Carozzi, F., Dalla, P. P., Giorgi-Rossi, P., Minucci, D., Naldoni, C., Segnan, N., Zappa, M., Zorzi, M., Cuzick, J., & NTCC Study Group. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment, Gynecol.Oncol., vol. 107, no. 1 Suppl 1, p. S230-S232. |
| Ronco, G., Cuzick, J., Pierotti, P., Cariaggi, M. P., Dalla, P. P., Naldoni, C., Ghiringhello, B., Giorgi-Rossi, P., Minucci, D., Parisio, F., Pojer, A., Schiboni, M. L., Sintoni, C., Zorzi, M., Segnan, N., Confortini, M., & NTCC working group. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial, BMJ, vol. 335, no. 7609, p. 28. |
| Ronco, G., Cuzick, J., Segnan, N., Brezzi, S., Carozzi, F., Folicaldi, S., Dalla, P. P., Del Mistro, A., Gillio-Tos, A., Giubilato, P., Naldoni, C., Polla, E., Iossa, A., Zorzi, M., Confortini, M., Giorgi-Rossi, P., & NTCC working group. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology, Eur.J.Cancer, vol. 43, no. 3, pp. 476-480. |
| Roychoudhuri, R., Robinson, D., Putcha, V., Cuzick, J., Darby, S., & Moller, H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study, BMC.Cancer, vol. 7, p. 9. |
| Santen, R. J., Boyd, N. F., Chlebowski, R. T., Cummings, S., Cuzick, J., Dowsett, M., Easton, D., Forbes, J. F., Key, T., Hankinson, S. E., Howell, A., Ingle, J., & Breast Cancer Prevention Collaborative Group. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model, Endocr.Relat Cancer, vol. 14, no. 2, pp. 169-187. |
| Sasieni, P. Cervical cancer prevention and hormonal contraception, Lancet, vol. 370, no. 9599, pp. 1591-1592. |
| Sasieni, P. Phenocopies in families seen by cancer geneticists, J.Med.Genet., vol. 44, no. 6, p. e82. |
| Shapiro, S. & Szarewski, A. Oral contraceptives, menopausal treatment, and cancer, Lancet Oncol., vol. 8, no. 10, pp. 867-868. |
| Shaw, G. L., Wilson, P., Cuzick, J., Prowse, D. M., Goldenberg, S. L., Spry, N. A., & Oliver, T. International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients, BJU.Int., vol. 99, no. 5, pp. 1056-1065. |
| Steliarova-Foucher, E., Arndt, V., Parkin, D. M., Berrino, F., & Brenner, H. Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System, Ann.Oncol., vol. 18, no. 9, pp. 1554-1560. |
| Swedish Organised Service Screening Evaluation Group (inc.Duffy S). Effect of mammographic service screening on stage at presentation of breast cancers in Sweden, Cancer, vol. 109, no. 11, pp. 2205-2212. |
| Szarewski, A. Cervical screening by visual inspection with acetic acid, Lancet, vol. 370, no. 9585, pp. 365-366. |
| Szarewski, A. Prophylactic HPV vaccines, Eur.J.Gynaecol.Oncol., vol. 28, no. 3, pp. 165-169. |
| Szarewski, A., Cadman, L., Mallett, S., Austin, J., Londesborough, P., Waller, J., Wardle, J., Altman, D. G., & Cuzick, J. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting, J.Med.Screen., vol. 14, no. 1, pp. 34-42. |
| Takousis, P., Johonnett, P., Williamson, J., Sasieni, P., Warnes, G., Forshew, T., Azuara, V., Fisher, A., Wu, P. J., Jones, T., Vatcheva, R., Beck, S., & Sheer, D. Replication Timing Profile Reflects the Distinct Functional and Genomic Features of the MHC Class II Region, Cell Cycle, vol. 6, no. 19. |
| Terry, G., Ho, L., Londesborough, P., Duggan, C., Hanby, A., & Cuzick, J. The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions, Br.J.Cancer, vol. 96, no. 1, pp. 110-117. |
|
